MedPath

University of Guadalajara

University of Guadalajara logo
🇲🇽Mexico
Ownership
Private
Established
1792-01-01
Employees
-
Market Cap
-
Website
http://www.udg.mx

Efect of Quinoa and Flaxseed in Cititoxicity and Glicemic Control in Metabolic Syndrome Patients

Not Applicable
Conditions
Metabolic Syndrome
Nutritional and Metabolic Diseases
Interventions
Other: Flaxseed
Other: Quinoa
Other: Quinoa and Flaxseed
First Posted Date
2019-04-16
Last Posted Date
2019-09-06
Lead Sponsor
University of Guadalajara
Target Recruit Count
90
Registration Number
NCT03915600
Locations
🇲🇽

Hospital Civil de Guadalajara "Fray Antonio Alcalde", Guadalajara, Jalisco, Mexico

🇲🇽

Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico

Decision Making With Bioethical Perspective in Palliative Care en Mexico

Completed
Conditions
Palliative Care
First Posted Date
2019-04-12
Last Posted Date
2020-12-11
Lead Sponsor
University of Guadalajara
Target Recruit Count
72
Registration Number
NCT03913390
Locations
🇲🇽

Rosa Margarita Alvarez Alvarez, Zapopan, Jalisco, Mexico

Effect of Phytoecdysterone Administration in Subjects With Prediabetes

Not Applicable
Conditions
PreDiabetes
Interventions
Dietary Supplement: Ecdysterone
Other: Placebo
First Posted Date
2019-04-08
Last Posted Date
2019-10-31
Lead Sponsor
University of Guadalajara
Target Recruit Count
34
Registration Number
NCT03906201
Locations
🇲🇽

Ana Fletes, Guadalajara, Jalisco, Mexico

Automated Diagnosis of Stroke in Computed Tomography With the Use of Artificial Intelligence

Conditions
Ischemic Stroke
Stroke
First Posted Date
2019-03-14
Last Posted Date
2021-05-18
Lead Sponsor
University of Guadalajara
Target Recruit Count
350
Registration Number
NCT03874702
Locations
🇲🇽

Departamento de neurociencias, Guadalajara, Jalisco, Mexico

Effect of Melatonin and Metformin on Glycemic Control Genotoxicity and Cytotoxicity Markers in Patients With Prediabetes

Phase 2
Conditions
PreDiabetes
Interventions
First Posted Date
2019-02-20
Last Posted Date
2019-09-26
Lead Sponsor
University of Guadalajara
Target Recruit Count
42
Registration Number
NCT03848533
Locations
🇲🇽

Institute of Experimental and Clinical Therapeutics (INTEC), CUCS, University of Guadalajara, Guadalajara, Jalisco, Mexico

Effect of Medicago Sativa on Oral Glucose Tolerance in Healthy Adults

Phase 2
Completed
Conditions
Glucose Tolerance
Interventions
Dietary Supplement: Placebo
First Posted Date
2018-10-22
Last Posted Date
2019-02-21
Lead Sponsor
University of Guadalajara
Target Recruit Count
15
Registration Number
NCT03714438
Locations
🇲🇽

Institute of Experimental and Clinical Therapeutics (INTEC), CUCS, University of Guadalajara, Guadalajara, Jalisco, Mexico

Effect of Dapagliflozin/Metformin XR vs Monotherapies on Anthropometric Indicators in Obesity

First Posted Date
2018-10-18
Last Posted Date
2023-05-23
Lead Sponsor
University of Guadalajara
Target Recruit Count
33
Registration Number
NCT03710460
Locations
🇲🇽

Instituto de Terapeútica Experimental y Clínica. Centro Universitario de Ciencias de la Salud. Universidad de Guadalajara, Guadalajara, Jalisco, Mexico

Combined Antioxidant Therapy on Oxidative Stress, Mitochondrial Dysfunction Markers in Diabetic Retinopathy

Phase 3
Completed
Conditions
Diabetic Retinopathy
Interventions
Drug: Combined antioxidant therapy
Other: Placebo
First Posted Date
2018-10-11
Last Posted Date
2022-04-01
Lead Sponsor
University of Guadalajara
Target Recruit Count
132
Registration Number
NCT03702374
Locations
🇲🇽

Institute of Experimental and Clinical Therapeutics,, Guadalajara, Jalisco, Mexico

Enalapril Maleate on Arterial Stiffness in Rheumatoid Arthritis.

Phase 2
Completed
Conditions
Rheumatoid Arthritis
Interventions
First Posted Date
2018-09-12
Last Posted Date
2018-11-14
Lead Sponsor
University of Guadalajara
Target Recruit Count
59
Registration Number
NCT03667131
Locations
🇲🇽

Instituto de Investigación en Reumatología y Sistema Músculo Esquelético, Guadalajara, Jalisco, Mexico

Amla on Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion

Phase 2
Completed
Conditions
Metabolic Syndrome
Interventions
Drug: Amla
Drug: Placebo
First Posted Date
2018-08-16
Last Posted Date
2022-11-08
Lead Sponsor
University of Guadalajara
Target Recruit Count
28
Registration Number
NCT03633630
Locations
🇲🇽

Institute of Experimental and Clinical Therapeutics, Guadalajara, Jalisco, Mexico

© Copyright 2025. All Rights Reserved by MedPath